Form 4 for TXG 10x Genomics, Inc.

Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001610717-26-000086 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MT	2026-03-04	2026-03-02	TXG	Saxonov Serge	CEO, Dir	S - Sale	$22.73	-16.2K	1.20M	-1%	-$367.1K
T	2026-03-04	2026-03-03	TXG	Saxonov Serge	CEO, Dir	G - Gift	$0.00	-2,750	1.20M	-0.2%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2026-03-02	S	D	14,292	$22.67	1,205,527	D	—	—	(F2) This transaction was executed in multiple trades at prices ranging from $22.15 to $23.145, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
2	Common	Class A Common Stock	2026-03-02	S	D	1,860	$23.18	1,203,667	D	—	—	(F3) This transaction was executed in multiple trades at prices ranging from $23.15 to $23.25, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3	Common	Class A Common Stock	2026-03-03	G	D	2,750	$0.00	1,200,917	D	—	—